Results 101 to 110 of about 277,874 (307)

On the Predictive Validity (Generalizability) of IELTS Academic Tests [PDF]

Teaching English Language, 2019
Predictive validity of high-stake tests has attracted the attention of applied linguists since a couple of decades ago. Despite the existence of a plethora of studies on reliability and validity issues of high stake tests, it seems that predictive ...
Goodarz Shakibaei, Mehran Memari
doaj  

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati, Sami I. Nassar, Shaun A. Nguyen, Patricia L. Gerend, Michael C. Schubert, Michael T. Teixido, Frederick A. Godley, Joel A. Goebel, Cynthia A. Ryan, Habib G. Rizk, Amir Kheradmand   +10 more
wiley   +1 more source

The Structured Employment Interview: An Examination of Construct and Criterion Validity

, 2006
This study extends the literature on interview validity by attempting to create a structured employment interview with both construct- and criterion-related validity.
Levine, Anne B.
core  

Hyper-parameter grid search predictive validity.

, 2018
Predictive validity metrics for the mean and standard deviation of attainment predictions of space-time distance model, over the grid of hyper-parameters tested using out-of-sample predictive validity.
Nicholas Graetz (5626766), Emmanuela Gakidou (250582), Joseph Friedman (6029804)   +2 more
core   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

La Utilidad del Análisis de Grupos Estratégicos para la Identificación de Opciones Estratégicas de Éxito

Tec Empresarial, 2013
En el presente trabajo, tratamos de llevar a cabo unavaloración de lo que realmente puede aportar el análisis degrupos estratégicos, no sólo como herramienta de reflexiónestratégica, sino como un constructo válido para explicar lasdiferencias en la ...
Lorenzo Revuelto Taboada, Rafael Fernández Guerrero   +1 more
doaj  

Responses to traumatic brain injury screening questions and suicide attempts among those seeking Veterans Health Administration mental health services

Frontiers in Psychiatry, 2016
Background: Psychometrically sound screening tools available to aid in the identification of lifetime history of traumatic brain injury (TBI) are limited.
Alexandra Lindsay Schneider, Trisha Ann Hostetter, Beeta Yazmeen Homaifar, Beeta Yazmeen Homaifar, Beeta Yazmeen Homaifar, Jeri Erica Forster, Jeri Erica Forster, Jeri Erica Forster, Bridget Bulman Matarazzo, Bridget Bulman Matarazzo, Jennifer H. Olson-Madden, Jennifer H. Olson-Madden, Jennifer H. Olson-Madden, Joe eHuggins, Lisa Anne Brenner, Lisa Anne Brenner, Lisa Anne Brenner, Lisa Anne Brenner   +17 more
doaj   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Predicting and validating microRNA targets.

Genome biology, 2004
Given that microRNAs select their targets by nucleotide base-pairing, it follows that it should be possible to find microRNA targets computationally. There has been considerable progress, but assessing success and biological significance requires a move into the 'wet' lab.
openaire   +2 more sources

The Attitudes about Complex Therapy Scale (ACTS) in Type 2 Diabetes and Cardiovascular Disease: Development, Validity and Reliability

, 2015
Background: Type 2 diabetes is associated with cardiovascular disease, and patients with both conditions are prescribed complex medication regimens. Aim: The aim was to develop a reliable and valid measure of attitudes associated with the prescription
Noyce, PR, Chris Bundy, Peter R Noyce, Stack, RJ, Martin Gibson, Elliott, RA, Rachel A Elliott, New, JP, Bundy, C, John P New, Rebecca J Stack   +10 more
core   +1 more source